{
  "id": "32b88f289ee99aa3",
  "title": "STAT+: FDA approves brain tumor warning on Depo-Provera label as court battle grows over side effects",
  "description": "The FDA has approved a change to the labeling for a Pfizer birth control shot that warns patients of the risk of meningioma, a type of tumor.",
  "content": "The FDA has approved a change to the labeling for a Pfizer birth control shot that warns patients of the risk of meningioma, a type of tumor.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2025/12/17/fda-pfizer-contraception-cancer-preemption-depoprovera/?utm_campaign=rss",
  "published_at": "2025-12-17T18:52:26+00:00",
  "fetched_at": "2025-12-18T00:22:47.263985+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: FDA approves brain tumor warning on Depo-Provera label as court battle grows over side effects",
    "description": "The FDA has approved a change to the labeling for a Pfizer birth control shot that warns patients of the risk of meningioma, a type of tumor.",
    "url": "https://www.statnews.com/pharmalot/2025/12/17/fda-pfizer-contraception-cancer-preemption-depoprovera/?utm_campaign=rss",
    "published": "2025-12-17T18:52:26+00:00",
    "source": "STAT"
  }
}